Respiratory specialists failed to block the Philip Morris acquisition of inhaler manufacturer Vectura. Now they are banding together to exclude tobacco-owned businesses from pulmonary research.
https://ift.tt/2Eascyi
from WebMD Health https://ift.tt/3rLhovw
by
Comments
Post a Comment